N4 Pharma, a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, welcomes the announcement of the move to make Viagra 50mg available as an Over The Counter (“OTC”) product in the UK.
In the press announcement on Wednesday, Nigel Theobald, CEO of N4 Pharma, said that, unlike in the USA, prescription products cannot be advertised directly to consumers in Europe and this move to OTC will make that possible in the UK for sildenafil.
He said: “The establishment of an OTC market for sildenafil in the UK will bring many opportunities for reformulated products as has happened in other OTC sectors. If this OTC status is widely supported by pharmacists in the UK, our 50mg reformulation of sildenafil will also be able to apply for OTC status.”
He concluded that the move is a great endorsement for our decision to reformulate sildenafil.
Image is for illustration purposes: A box of Pfizer drug Viagra and a bottle of Allergan product Botox are seen in a combination of file photos. REUTERS/Mark Blinch/Shannon Stapleton/Files